ITGAX and systemic lupus erythematosus: However, given that they contribute to the pathogenesis of SLE, and their clear susceptibility to A2A receptor-mediated elimination, we propose that depletion of CD11c+T-bet+ B cells is a major mechanism by which CGS-21680 treatment reduces disease in MRL/lpr mice.